Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Efficacy and Safety of Ivermectin for COVID-19 Prophylaxis in Post-exposure Contact or Epidemiological Link

NCT04894721 is registered in ClinicalTrials.gov with Ministry of Public Health, Argentina as lead sponsor.

NCT NCT04894721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04894721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Efficacy and Safety of Ivermectin for COVID-19 Prophylaxis in Post-exposure Contact or Epidemiological Link
Lead sponsor
Ministry of Public Health, Argentina
Phase
Phase 2/3
Overall status
Completed
Start date
June 1, 2021
Completion date
October 1, 2021
Enrollment
172 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19